Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

CD33 ANTIBODIES AND METHODS OF USING THE SAME TO TREAT CANCER

METHODS AND COMPOSITIONS FOR THE IMPROVEMENT OF LYSOSOMAL FUNCTION AND TREATMENT OF NEURODEGENERATIVE DISEASE

Binding moieties for biofilm remediation

HUMAN APOB100 EPITOPES, METHODS AND USES FOR MODULATING INFLAMMATORY RESPONSES, AND TREATING ADVERSE CARDIOVASCULAR EVENTS, DISEASE AND ATHEROSCLEROSIS

CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION

CD73 INHIBITORS

SUBSTITUTED DIAZAHETERO-BICYCLIC COMPOUNDS AND THEIR USE

Tetracyclic heterocycle compounds useful as HIV integrase inhibitors

SUBSTITUTED PYRAZOLOQUINAZOLINONE COMPOUNDS AND APPLICATION THEREOF

Pyrazolone-Fused Pyrimidine Compound, Preparation Method for Same and Applications Thereof

CRYSTALLINE FORMS OF A CYCLIN-DEPENDENT KINASE INHIBITOR

DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

CHEMICAL INHIBITORS OF ID PROTEINS FOR THE TREATMENT OF CANCER AND OTHER DISEASES

ANTIBACTERIAL AND ANTIPARASITIC QUINOXALINE-2,3-DIAMINE DERIVATIVES

Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof

Compounds and methods for the targeted degradation of androgen receptor

MICRONIZED DRUG RESINATE-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREPARATION THEREOF

β-lactam-cannabinoid conjugate molecules

COMPOSITIONS COMPRISING LOPINAVIR AND TREATMENT OF CONDITIONS

SSTR-TARGETED CONJUGATES AND FORMULATIONS THEREOF

Anti-LAG3 antibodies and antigen-binding fragments

Therapeutic composition and method combining multiplex immunotherapy with cancer vaccine for the treatment of cancer

FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE

METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE

USE OF HISTONE DEUBIQUITINASE IN PREPARING DRUG FOR PREVENTING AGING AND TREATING AGING-RELATED DISEASES

PHARMACEUTICAL COMPOSITION CONTAINING LYSOZYME AND USE THEREOF

P21 Expressing Monocytes for Cancer Cell Therapy

Proteins for the treatment of epithelial barrier function disorders

METHODS AND COMPOSITIONS FOR TREATMENT OF ENDOTHELIN B RECEPTOR EXPRESSING TUMORS

ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF CANCER

Treatment of women affected with polycystic ovary syndrome

PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES

Synergistic bacterial compositions and methods of production and use thereof

Methods for treating or preventing obesity and body weight management

REDUCTION OF BONE RESORPTION, ESPECIALLY IN CHRONIC JOINT DISEASES

MICROLUMENAL TARGETING OF CANCER CELLS

ADMINISTRATION OF STING AGONIST AND CHECKPOINT INHIBITORS

Pemafibrate dosing regimens

FORMULATIONS AND DOSAGES FOR ADMINISTERING A COMPOUND THAT INHIBITS MCL1 PROTEIN

METHOD FOR TREATMENT OF MUSCULAR DYSTROPHY

NOVEL USE OF PYRROLOPYRIDINE DERIVATIVES FOR PREVENTING OR TREATING INFLAMMATORY DISEASES

COMBINATION THERAPY FOR TREATING MTAP-DEFICIENT TUMORS

ALKYNE DERIVATIVE, PREPARATION METHOD FOR SAME, AND USES THEREOF

INHIBITORS OF PRC1 FOR TREATMENT OF CANCER

METHODS USEFUL IN TREATING CANCERS HARBORING A KRAS OR HRAS MUTATION OR AMPLIFICATION

Use of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline for Treating Neurodegenerative Diseases, Preferably Alzheimer's Disease

MACITENTAN FOR USE IN TREATING PORTOPULMONARY HYPERTENSION

TRANSITIONING PATIENTS TREATED FOR PULMONARY ARTERIAL HYPERTENSION TO SELEXIPAG

METHOD OF TREATING DYSKINESIA

NLRP3 modulators

INHIBITOR OF MAP KINASE INTERACTING SERINE/THREONINE KINASE 1 (MNK1) AND MAP KINASE INTERACTING SERINE/THREONINE KINASE 2 (MNK2), CANCER THERAPY AND THERAPEUTIC COMBINATIONS

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CORONAVIRUS DISEASE-19

Methods for restoring stem cell pools and reducing epigenetic age

Pharmaceutical combination for the treatment of a cancer

METHODS OF PRESCREENING AND TREATING BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATORS

AMORPHOUS SOLID FORM OF COMPOUNDS CONTAINING S-N-VALERYL-N-{[2'-(1H-TETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND SODIUM CATIONS

Oral combination drug formulation comprising a non-steroidal anti-inflammatory drug and a complementary low dose of tranexamic acid for the treatment of menstrual pain accompanied with excessive menstrual blood loss

ORALLY ADMINISTRABLE MODIFIED-RELEASE PHARMACEUTICAL DOSAGE FORM

THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF MITOTIC KINASE INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR

Surface Modified Gas Vesicles, Preparation and Applications thereof

VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

METHODS OF USING PD-L1 EXPRESSION IN TREATMENT DECISIONS FOR CANCER THERAPY

Estrogen receptor mutations and uses thereof

MEMBRANE ATTACK COMPLEXES AND USES THEREOF

Methods and compositions related to RNA-targeted Rho small GTPase RND3/RhoE therapy

LEVODOPA POLYMERIC CONJUGATES, FORMULATIONS THEREOF, AND THEIR USES FOR THE TREATMENT OF PARKINSON'S DISEASE

Multi-specific binding proteins for cancer treatment

MONOCLONAL ANTIBODIES AND METHODS OF USE

PHARMACEUTICAL COMBINATION AND METHOD FOR OVERCOMING IMMUNE SUPPRESSION OR STIMULATING IMMUNE RESPONSE AGAINST CANCER

ANTI-PD-L1 COMBINATIONS FOR TREATING TUMORS

ANTI-CD79B ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE

ANTI-TIGIT ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

ANTI-PD-1/LAG3/TIGIT TRISPECIFIC ANTIBODIES AND ANTI-PD-1/LAG3 BICPECIFIC ANTIBODIES

THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING CANCER IN COMBINATION WITH ANALOGS OF INTERLEUKIN PROTEINS

AGENTS THAT INTERFERE WITH THYMIC STROMAL LYMPHOPOIETIN (TSLP)-RECEPTOR SIGNALING

TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIESHEREOF

METHODS AND COMPOSITIONS RELATING TO ANTI-NUCLEOLIN RECOMBINANT IMMUNOAGENTS

GIP AND GLP-1 DUAL AGONIST POLYPEPTIDE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT AND APPLICATION THEREOF

NON-HYDROLYZABLE NON-CLEAVABLE, STABLE LINKERS FOR PRECISION THERAPEUTICS AND USES THEREOF

ALKYLBORONIC ACIDS AS ARGINASE INHIBITORS

NON-IMMUNOSUPPRESSIVE FK506 ANALOGS AND USE THEREOF

Compositions and methods for treating atopic dermatitis

Cyclic iminopyrimidine derivatives as kinase inhibitors

Protein tyrosine phosphatase inhibitors

Solid forms of an HIV capsid inhibitor

INHIBITORS OF BACTERIAL PASTA KINASES

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

HETEROCYCLIC INHIBITORS OF MCT4

MCT4 inhibitors for treating disease

COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING IMMUNE CHECKPOINT INHIBITOR-RESISTANT CANCER

POLYMERIC DRUG DELIVERY CONJUGATES AND METHODS OF MAKING AND USING THEREOF

METHODS AND COMPOSITIONS FOR CANCER TREATMENT AND TREATMENT SELECTION

Methods Of Treatment Of Keloid Using An Anti-VEGF Agent

ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND DIHYDROPYRIMIDINE DERIVATIVES AS CAPSID ASSEMBLY MODULATORS

Indoleamine 2,3-dioxygenase based immunotherapy

TREATMENT OF CANCERS USING sEphB4-HSA FUSION PROTEINS

CYCLODEXTRIN BASED INJECTABLE COFORMULATIONS OF SGLT2 INHIBITORS AND INCRETIN PEPTIDES

Method of Treating Peripheral Nerve Disorders

Treatment of Mood and Anxiety Disorders

Combination Therapy for Treating Disorders of the Ear

PEPTIDES AND METHODS OF TRANSPLANTATION AND RESTORATIVE ORGAN FUNCTION

Antimicrobial compositions and methods of use thereof

COMPOSITION FOR THE TREATMENT OF EMOTIONAL DISORDERS

NOVEL LACTIC ACID BACTERIA STRAIN - ANTIBACTERIAL PEPTIDES PRODUCED BY SAID STRAIN AND RELATED PHARMACEUTICAL COMPOSITIONS

SECRETED MICROBIAL EXTRACELLULAR VESICLES

COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTH

PDL1 POSITIVE NK CELL CANCER TREATMENT

A COMPOSITION, A KIT AND USE THEREOF

Platinum-Based Chemotherapy, Mast Binding Agents, Glucocorticoid Receptor (GR) Binding Agents, and/or HSP90 Binding Agents for Uses in Treating Cancer

COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF

Combination therapy for HIV with adenosine derivative and capsid inhibitors

USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE

COMPOSITIONS AND METHODS FOR TREATING NONINFECTIOUS UVEITIS

TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING DILTIAZEM

USE OF ESREBOXETINE TO TREAT NERVOUS SYSTEM DISORDERS SUCH AS FIBROMYALGIA

METABOLITES OF BICTEGRAVIR

USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)

ANTICANCER COMBINATION THERAPY

GENE THERAPY FOR MESOTHELIOMA

METHOD FOR TREATING CANCER USING A COMBINATION OF CHK1 AND ATR INHIBITORS

N2,N4-DIPHENYLPYRIMIDINE-2,4-DIAMINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

TREATING NEURAL DISEASE WITH TYROSINE KINASE INHIBITORS

APPLICATION OF FLUORO-SUBSTITUTED 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDE

Methods and compositions for treating viral or virally-induced conditions

MutL LOSS PREDICTS SENSITIVITY TO CDK4/6 INHIBITORS IN CANCER

COMPOUNDS AND METHOD FOR TREATING CYTOKINE RELEASE SYNDROME

NEW THERAPEUTIC APPROACH TO LUNG DISEASE

Anticancer drug FL118 formulation for treatment of human cancer

Choline salt forms of an HIV capsid inhibitor

Agonists Of Adiponectin

INHIBITORS OF MONOCARBOXYLATE TRANSPORTERS FOR CANCER IMMUNOTHERAPY

Regimen for suppressing organ rejection

CF3-, OCF3-, SCF3-, and SF5-Containing Antibacterial Agents

Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans

BENZOQUINONE DERIVATIVES FOR THE TREATMENT OF BLADDER CANCER

Threonate Compounds and Methods of Use Thereof

Surfactant peptide nanostructures and uses thereof in drug delivery

DELAYED DELIVERY OF ANTICANCER DRUGS

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target Cell

MOISTURIZING COMPOSITIONS AND USES THEREOF

CHEWING GUM COMPOSITIONS FOR THE TREATMENT OF MENOPAUSAL SYMPTOMS

METHODS FOR TREATING SMALL CELL NEUROENDOCRINE AND RELATED CANCERS

Compositions and Methods for Monitoring, Diagnosis, Detection and Treatment of Cancer

NTRK FUSION MOLECULES AND USES THEREOF

APPLICATION OF CIRCULAR RNA IN PREPARING DRUG FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

COMPOSITIONS AND METHODS FOR REGULATING ERYTHROPOIESIS

USES OF ANTI-SIRPg ANTIBODIES

PROVASOPRESSIN ANTAGONISTS AND USES THEREOF

C3D CELLULAR AND ACELLULAR VACCINES FOR THE PREVENTION AND TREATMENT OF CANCER

INHIBITORS OF IL-15 AND THEIR USE IN TREATING AUTOIMMUNE/INFLAMMATORY DISORDERS

SMALL-MOLECULE FOCAL ADHESION KINASE (FAK) INHIBITORS

FUSED HETEROCYCLE DERIVATIVES

Imidazopyrimidine compounds and uses thereof

INHIBITORS OF CYCLIN-DEPENDENT KINASES

IMIDAZOPYRIDINYL COMPOUNDS AND USE THEREOF FOR TREATMENT OF PROLIFERATIVE DISORDERS

Fused Imidazole Derivatives as IL-17 Modulators

Substituted 1,3,5-triazines as inhibitors for a rho family of GTP-ases

PYRIDINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS

COMPOUND FOR TREATING GOUT OR HYPERURICEMIA

Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof

Methods for making and using endoxifen

CRYSTAL FORM OF TREPROSTINIL SODIUM SALT AND PREPARATION METHOD THEREFOR

ANTICANCER COMBINATIONS

DRUG DELIVERY COMPOSITION AND PHARMACEUTICAL COMPOSITION

IL-6 antagonist formulations and uses thereof

MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME

COMBINATION IMMUNOTHERAPY APPROACH FOR TREATMENT OF CANCER

METHODS AND USES FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES

ATTENUATED YELLOW FEVER VIRUS AND USES THEREOF FOR THE TREATMENT OF CANCER

Direct-fed microbials

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE GASTROINTESTINAL SYSTEM

COMPOSITIONS AND METHODS FOR PROVIDING CHEMOPROTECTIVE EFFECTS

THERAPEUTIC USES OF OXIDISING HYPOTONIC ACID SOLUTIONS

BIOLOGICAL POLYSACCHARIDE HAVING EFFECT OF PREVENTING AND TREATING HORMONE-DEPENDENT DERMATITIS AND APPLICATION THEREOF

Altering microbial populations and modifying microbiota

BISFLUOROALKYL-1,4-BENZODIAZEPINONE COMPOUNDS FOR TREATING NOTCH-ACTIVATED BREAST CANCER

Drug for preventing and/or treating polycystic kidney disease

METHODS OF TREATING SOLID TUMORS WITH CCR2 ANTAGONISTS

COMPOSITIONS AND METHOD OF TREATING CANCER

Treatment of hidradenitis suppurativa using JAK inhibitors

Imidazopyrimidine Derivatives

COMPOSITIONS AND METHODS FOR TREATING CANCER

TARGETED TREATMENT OF CANCERS WITH DYSREGULATED FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING

Cannabinoid receptor modulators

USE OF SGC ACTIVATORS FOR THE TREATMENT OF OPHTHALMOLOGIC DISEASES

METHODS OF TREATING FIBROSIS USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION

INHALABLE DRY POWDERS

METHODS AND PHARMACEUTICAL COMPOSITIONS TO TREAT DRUG OVERDOSE

SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES

COMBINATIONS OF INHIBITORS OF IRAK4 WITH INHIBITORS OF BTK

COMBINATION CONTAINING SGC ACTIVATORS AND MINERALOCORTICOID RECEPTOR ANTAGONISTS

USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS

Combination of small molecule CD-47 inhibitors with other anti-cancer agents

METHODS OF TREATING MIXED DYSLIPIDEMIA

METHOD FOR TREATMENT OF AT RISK PATIENTS

Methods and Compositions for Altering Senescence Associated Secretory Phenotype

NANOPARTICLES COMPRISING QUINONE W METHIDES AND COMPOSITIONS FOR USE

Synthetic progestogens and pharmaceutical compositions comprising the same

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HBV

METHOD FOR PRODUCTION OF LIPOSOMES

PHARMACEUTICAL COMPOSITIONS IN THE FORM OF GEL CONTAINING XYLOGLUCAN AND ALCOHOLS FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS

MODIFIED RELEASE DRUG POWDER COMPOSITION COMPRISING GASTRO-RETENTIVE RAFT FORMING SYSTEMS HAVING TRIGGER PULSE DRUG RELEASE

ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS

FIBRIN BIOPOLYMER FORMATION AND APPLICATION DEVICE

METHODS FOR MODULATING A TREATMENT REGIMEN

Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer

RNAi Inhibition of Alpha-ENaC Expression

ANTI-CD137 ANTIBODIES AND METHODS OF USE THEREOF

COMBINATION THERAPIES USING CDK INHIBITORS

METHODS AND COMPOSITIONS FOR TREATING A DISEASE OR DISORDER

Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)

Method to engineer transplantable human tissues

PROGESTERONE ANALOGS AND USES RELATED THERETO

MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE

Crystalline forms of Tenofovir alafenamide

ARTEMISININ-DERIVATIVE N-HETEROCYCLIC CARBENE GOLD(I) HYBRID COMPLEXES

Oxabicycloheptane prodrugs

A MEDICAMENT FOR TREATING MYCOBACTERIAL INFECTION CHARACTERIZED BY COMBINING A CYTOCHROME bc1 INHIBITOR WITH CLARITHROMYCIN OR AZITHROMYCIN AND CLOFAZIMINE

COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS

SELECTIVE HISTAMINE H3 RECEPTOR ANTAGONISTS FOR TREATING AUTISM SPECTRUM DISORDER

METHODS USING HDAC11 INHIBITORS

SONODYNAMIC THERAPY

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS

CELL LOCALIZATION SIGNATURE AND COMBINATION THERAPY

CAMKK1 AS A NOVEL REGENERATIVE THERAPEUTIC

ORAL ADMINISTRATION OF UNSTABLE OR POORLY-ABSORBED DRUGS

ANTI-CANCER AND ANTI-PROLIFERATIVE COMPOSITIONS, AND METHODS FOR THEIR USE IN TREATING CANCER

AN AMNIOTIC FLUID COMPOSITION AND METHOD OF USING

USE OF WHEY PROTEIN MICELLES FOR CONTROLLING POSTPRANDIAL GLUCOSE RESPONSE

TARGETING OTUB1 IN IMMUNOTHERAPY

COMPOSITIONS AND METHODS OF USING SAME FOR TISSUE REGENERATION

Solute carrier family 46 member 3 (SLC46A3) as marker for lipid-based nanoparticle cancer therapy and diagnostics

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

METHODS AND COMPOSITIONS FOR TREATING PULMONARY ARTERIAL HYPTERNSION

OLIGOSACCHARIDE COMPOSITIONS AND METHODS OF USE

METHOD AND COMPOSITION FOR PREDICTING EFFICACY OF BCL2/BCL-XL INHIBITORS ON CANCER

Combination therapy effective against microorganisms, including drug resistant microorganisms

COMPOSITIONS AND METHODS FOR USING ANDROGEN SIGNALING INHIBITORS

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED PULMONARY ARTERIAL HYPERTENSION

Pyruvate kinase modulators and use thereof

COMPOSITIONS AND METHODS FOR INHIBITING TCF/LEF TRANSCRIPTIONAL ACTIVITY

COMPOSITIONS AND METHODS FOR INHIBITING HEDGEHOG PATHWAY

Fast dissolving pharmaceutical compositions

INTERMITTENT DOSING OF MDM2 INHIBITOR

Compositions and use of varenicline for treating dry eye

ANTIBIOTIC POTENTIATION FOR NONTUBERCULOUS MYCOBACTERIAL DISEASE

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE AND COMBINATION THERAPIES THEREOF

METHODS AND AGENTS THAT STIMULATE MITOCHONDRIAL TURNOVER FOR TREATING DISEASE

Cannabinoid derivatives and methods for their preparation

Antibiotic cannabinoid-terpene formulations

METHOD, COMPOSITION AND PACKAGE FOR BOWEL CLEANSING

COMPOSITIONS FOR TREATMENT OF SUBSTANCE USE DISORDER

IRON SUPPLEMENT

NOVEL D3 DOPAMINE RECEPTOR AGONISTS TO TREAT DYSKINESIA IN PARKINSON'S DISEASE

MICROEMULSION DELIVERY SYSTEMS FOR CANNABIS EXTRACTS AND TERPENES

NANO- OR MICRO-EMULSION COMPOSITIONS AND METHODS OF USE THEREOF

MICELLE FOR SOLUBILIZING A SPARINGLY WATER-SOLUBLE INGREDIENT AND SOLUTION COMPRISING THE SAME

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA

WILDLIFE SUPPLEMENTATION METHODS AND RELATED COMPOSITION

DETECTION OF DESMOGLEIN-2 IN CANCERS OF EPITHELIAL ORIGIN

CD8+ T-CELLS LACKING PLEXINS AND THEIR APPLICATION IN CANCER TREATMENT

BISPECIFIC BINDING CONSTRUCTS WITH SELECTIVELY CLEAVABLE LINKERS

MONOCLONAL ANTIBODY AND A METHOD OF USE FOR THE TREATMENT OF LUPUS

ANTI-HVEM ANTIBODIES AND USE THEREOF

RANK ANTAGONISTS AND USES THEREOF

Multispecific Anti-HIV Antibodies

Neutralizing anti-SARS-CoV-2 antibodies

FGF21 VARIANTS

COMPOSITIONS AND METHODS USEFUL IN TREATING BRAIN DISEASES

CYCLIC DOMINANT NEGATIVE COMPETENCE STIMULATING PEPTIDE ANALOGS AND METHODS OF TREATING STREPTOCOCCUS PNEUMONIAE INFECTIONS

Treatments for Gastrointestinal Disorders

Imidazopyrimidines as EED inhibitors and the use thereof

PYRIDO-INDOLE ANALOGUES AS GPX4 INHIBITORS

Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

NOVEL DIHYDROPYRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS.

METHODS AND COMPOSITIONS FOR PREVENTION OF ANAPHYLAXIS

Benzodiazepine derivatives as RSV inhibitors

COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR

DEGRADERS OF CYCLIN-DEPENDENT KINASE 12 (CDK12) AND USES THEREOF

TREATMENT OF FIBROSIS WITH IRE1 SMALL MOLECULE INHIBITORS

IDENTIFICATION AND USE OF KRAS INHIBITORS

ALLOSTERIC ACTIVATORS OF THE ALPHA1A-ADRENERGIC RECEPTOR

BENZIMIDAZOLE AND HYDROGENATED CARBAZOLE DERIVATIVES AS GPX4 INHIBITORS

LIGAND-DRUG CONJUGATE INCLUDING LINKER HAVING TRIS STRUCTURE

Peptide saporin conjugate for the treatment of cancer

WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS AND METHODS OF DELIVERING BIOLOGICALLY ACTIVE SUBSTANCES

ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER

Nucleic acid nanocarrier drug and preparation method thereof, pharmaceutical composition and application thereof

ANTIBODIES AND METHODS FOR TREATMENT OF INFLUENZA A INFECTION

THERAPEUTIC SIRP-ALPHA ANTIBODIES

Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses

ANTIGENIC COMPOSITION(S) AND METHOD(S) OF USE AGAINST PORPHYROMONAS GINGIVALIS FOR THE PREVENTION AND/OR TREATMENT OF INFECTION AND/OR DISEASES

NEUROTOXIN COMPOSITIONS FOR USE IN IMPROVING LUNG FUNCTION

MODULATION OF CANCER IMMUNITY WITH TYPE 2 INNATE LYMPHOID CELLS, INTERLEUKIN 33, AND/OR INTERFERON INDUCED PROTEIN 44

Anti-angiogenic treatment using VLO4 with a blocking peptide